Skip to main content
Erschienen in:

28.09.2018 | Laryngology

The identification of induction chemo-sensitivity genes of laryngeal squamous cell carcinoma and their clinical utilization

verfasst von: Lianhe Li, Ru Wang, Shizhi He, Xixi Shen, Fanyong Kong, Shuchun Li, Huanhu Zhao, Meng Lian, Jugao Fang

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To identify potential molecular markers for induction chemotherapy of Laryngeal squamous cell carcinoma (LSCC).

Methods

Differently expressed genes between chemo-sensitive group (seven cases) and chemo-insensitive (five cases) group after induction chemotherapy by TPF were identified by microarrays. Bayes network and Random forest analyses were employed to identify core genes for induction chemotherapy. The diagnostic value of these core genes was also evaluated by ROC analysis.

Results

Six genes (SPP1, FOLR3, KYNU, LOC653219, ADH7 and XAGE1A) are highly expressed, while seven gene (CADM1, NDUFA4L2, CCND2, RARRES3, ERAP2, LYD6 and CNTNAP2) present significantly low expression. Among these genes, genes CADM1, FOLR3, KYNU, and CNTNAP2 are core candidates for LSCC chemo-sensitivity. And that the low expression of CADM1 may result in chemo-sensitivity, which leads to high expression of gene FOLR3 and KYNU, and low expression of gene CNTNAP2. Besides, ROC analysis shows that these four genes exhibit effective diagnostic value for induction chemo-sensitivity.

Conclusions

CADM1 may be a potential molecular marker for LSCC induction chemotherapy, while CADM1, FOLR3, KYNU, and CNTNAP2 may provide essential guidance for LSCC diagnosis and follow-up treatment strategies.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Mcguire S (2016) World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv Nutr 7:418–419CrossRef Mcguire S (2016) World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. Adv Nutr 7:418–419CrossRef
2.
Zurück zum Zitat Joanna J, Marcin S, Magdalena KP, Kinga B, Julia P, Joanna J, Reidar G, Krzysztof S, Malgorzata W, Maciej G (2015) Global miRNA expression profiling identifies miR-1290 as novel potential oncomiR in laryngeal carcinoma. Plos One 10:e0144924CrossRef Joanna J, Marcin S, Magdalena KP, Kinga B, Julia P, Joanna J, Reidar G, Krzysztof S, Malgorzata W, Maciej G (2015) Global miRNA expression profiling identifies miR-1290 as novel potential oncomiR in laryngeal carcinoma. Plos One 10:e0144924CrossRef
3.
Zurück zum Zitat Rudolph E, Dyckhoff G, Becher H, Dietz A, Ramroth H (2011) Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis. Eur Arch Otorhinolaryngol 268:165–179CrossRef Rudolph E, Dyckhoff G, Becher H, Dietz A, Ramroth H (2011) Effects of tumour stage, comorbidity and therapy on survival of laryngeal cancer patients: a systematic review and a meta-analysis. Eur Arch Otorhinolaryngol 268:165–179CrossRef
4.
Zurück zum Zitat Chu EA, Kim YJ (2008) Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am 41:673–695CrossRef Chu EA, Kim YJ (2008) Laryngeal cancer: diagnosis and preoperative work-up. Otolaryngol Clin North Am 41:673–695CrossRef
5.
Zurück zum Zitat Marioni G (2012) Essentials for an updated epidemiology of laryngeal carcinoma. Cancer Treat Rev 38:559–559CrossRef Marioni G (2012) Essentials for an updated epidemiology of laryngeal carcinoma. Cancer Treat Rev 38:559–559CrossRef
6.
Zurück zum Zitat Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29CrossRef Siegel R, Ma J, Zou Z, Jemal A (2014) Cancer statistics, 2014. CA Cancer J Clin 64:9–29CrossRef
7.
Zurück zum Zitat Zhang SY, Lu ZM, Luo XN, Chen LS, Ge PJ, Song XH, Chen S, Wu YL (2013) Correction: retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment. Plos One 8:95–98 Zhang SY, Lu ZM, Luo XN, Chen LS, Ge PJ, Song XH, Chen S, Wu YL (2013) Correction: retrospective analysis of prognostic factors in 205 patients with laryngeal squamous cell carcinoma who underwent surgical treatment. Plos One 8:95–98
8.
Zurück zum Zitat Corry J, Rischin D, Cotton S, D’Costa I, Chua M, Vallance N, Lyons B, Kleid S, Sizeland A, Peters LJ (2011) Larynx preservation with primary non-surgical treatment for loco-regionally advanced larynx cancer. J Med Imaging Radiat Oncol 55:229–235CrossRef Corry J, Rischin D, Cotton S, D’Costa I, Chua M, Vallance N, Lyons B, Kleid S, Sizeland A, Peters LJ (2011) Larynx preservation with primary non-surgical treatment for loco-regionally advanced larynx cancer. J Med Imaging Radiat Oncol 55:229–235CrossRef
9.
Zurück zum Zitat Kulc’Ar ZKMD, Konic-Carnelutti Z (1975) Epidemiology of laryngeal cancer. Laryngoscope 85:1155–1161CrossRef Kulc’Ar ZKMD, Konic-Carnelutti Z (1975) Epidemiology of laryngeal cancer. Laryngoscope 85:1155–1161CrossRef
10.
Zurück zum Zitat Siegel R, Ms DNM, Dvm AJ (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29CrossRef Siegel R, Ms DNM, Dvm AJ (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10–29CrossRef
11.
Zurück zum Zitat Devlin JG, Langer CJ (2007) Combined modality treatment of laryngeal squamous cell carcinoma. Expert Rev Anticancer Ther 7:331–350CrossRef Devlin JG, Langer CJ (2007) Combined modality treatment of laryngeal squamous cell carcinoma. Expert Rev Anticancer Ther 7:331–350CrossRef
12.
Zurück zum Zitat Lefebvre JL (2006) Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol 7:747–755CrossRef Lefebvre JL (2006) Laryngeal preservation in head and neck cancer: multidisciplinary approach. Lancet Oncol 7:747–755CrossRef
13.
Zurück zum Zitat Vermorken JB, Remenar E, Van HC, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695–1704CrossRef Vermorken JB, Remenar E, Van HC, Gorlia T, Mesia R, Degardin M, Stewart JS, Jelic S, Betka J, Preiss JH (2007) Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 357:1695–1704CrossRef
14.
Zurück zum Zitat Argiris A (2005) Induction chemotherapy for head and neck cancer: will history repeat itself? J Natl Compr Cancer Netw JNCCN 3:393–403CrossRef Argiris A (2005) Induction chemotherapy for head and neck cancer: will history repeat itself? J Natl Compr Cancer Netw JNCCN 3:393–403CrossRef
15.
Zurück zum Zitat Xu CZ, Xie J, Jin B, Chen XW, Sun ZF, Wang BX, Dong P (2013) Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line. Int J Clin Exp Pathol 6:1351–1361PubMedPubMedCentral Xu CZ, Xie J, Jin B, Chen XW, Sun ZF, Wang BX, Dong P (2013) Gene and microRNA expression reveals sensitivity to paclitaxel in laryngeal cancer cell line. Int J Clin Exp Pathol 6:1351–1361PubMedPubMedCentral
16.
Zurück zum Zitat Keil E, HÖcker R, Schuster M, Essmann F, Ueffing N, Hoffman B, Liebermann DA, Pfeffer K, Schulze-Osthoff K, Schmitz I (2013) Phosphorylation of Atg5 by the Gadd45β-MEKK4-p38 pathway inhibits autophagy. Cell Death Differ 20:321–332CrossRef Keil E, HÖcker R, Schuster M, Essmann F, Ueffing N, Hoffman B, Liebermann DA, Pfeffer K, Schulze-Osthoff K, Schmitz I (2013) Phosphorylation of Atg5 by the Gadd45β-MEKK4-p38 pathway inhibits autophagy. Cell Death Differ 20:321–332CrossRef
17.
Zurück zum Zitat Yim WC, Min K, Jung D, Lee BM, Kwon Y (2011) Cross experimental analysis of microarray gene expression data from volatile organic compounds treated targets. Mol Cell Toxicol 7:233–241CrossRef Yim WC, Min K, Jung D, Lee BM, Kwon Y (2011) Cross experimental analysis of microarray gene expression data from volatile organic compounds treated targets. Mol Cell Toxicol 7:233–241CrossRef
18.
Zurück zum Zitat Nambiar PR, Boutin SR, Raja R, Rosenberg DW (2005) Global gene expression profiling: a complement to conventional histopathologic analysis of neoplasia. Vet Pathol 42:735–752CrossRef Nambiar PR, Boutin SR, Raja R, Rosenberg DW (2005) Global gene expression profiling: a complement to conventional histopathologic analysis of neoplasia. Vet Pathol 42:735–752CrossRef
19.
Zurück zum Zitat Colombo J, Fachel AA, De FCM, Cury PM, Fukuyama EE, Tajara EH, Cordeiro JA, Verjovskialmeida S, Reis EM, Rahal P (2009) Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma. Oncol Rep 21:649–663PubMed Colombo J, Fachel AA, De FCM, Cury PM, Fukuyama EE, Tajara EH, Cordeiro JA, Verjovskialmeida S, Reis EM, Rahal P (2009) Gene expression profiling reveals molecular marker candidates of laryngeal squamous cell carcinoma. Oncol Rep 21:649–663PubMed
20.
Zurück zum Zitat Lian M, Fang J, Han D, Ma H, Feng L, Wang R, Yang F (2013) Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma. Plos One 8(12):e84854CrossRef Lian M, Fang J, Han D, Ma H, Feng L, Wang R, Yang F (2013) Microarray gene expression analysis of tumorigenesis and regional lymph node metastasis in laryngeal squamous cell carcinoma. Plos One 8(12):e84854CrossRef
21.
Zurück zum Zitat Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374–378CrossRef Saeed AI, Sharov V, White J, Li J, Liang W, Bhagabati N, Braisted J, Klapa M, Currier T, Thiagarajan M (2003) TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34:374–378CrossRef
22.
Zurück zum Zitat Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:1–25CrossRef Smyth GK (2004) Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:1–25CrossRef
23.
Zurück zum Zitat Mcardle BH, Anderson MJ (2001) Fitting multivariate models to community data: a comment on distance-based redundancy analysis. Ecology 82:290–297CrossRef Mcardle BH, Anderson MJ (2001) Fitting multivariate models to community data: a comment on distance-based redundancy analysis. Ecology 82:290–297CrossRef
24.
Zurück zum Zitat Jiang Y, Zhang R, Lv H, Li J, Wang M, Chang Y, Lv W, Xin S, Zhang J, Liu P (2013) HGPGD: the human gene population genetic difference database. Plos One 8:e64150CrossRef Jiang Y, Zhang R, Lv H, Li J, Wang M, Chang Y, Lv W, Xin S, Zhang J, Liu P (2013) HGPGD: the human gene population genetic difference database. Plos One 8:e64150CrossRef
25.
Zurück zum Zitat Consortium TGO (2008) The gene ontology project in 2008. Nucleic Acids Res 36:440–444CrossRef Consortium TGO (2008) The gene ontology project in 2008. Nucleic Acids Res 36:440–444CrossRef
26.
Zurück zum Zitat Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27:29–34CrossRef Ogata H, Goto S, Sato K, Fujibuchi W, Bono H, Kanehisa M (2000) KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 27:29–34CrossRef
27.
Zurück zum Zitat Wahde M, Hertz J (2000) Coarse-grained reverse engineering of genetic regulatory networks. Biosystems 55:129–136CrossRef Wahde M, Hertz J (2000) Coarse-grained reverse engineering of genetic regulatory networks. Biosystems 55:129–136CrossRef
29.
Zurück zum Zitat Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics for African Americans, 1996. CA Cancer J Clin 46:113–125CrossRef Parker SL, Tong T, Bolden S, Wingo PA (1996) Cancer statistics for African Americans, 1996. CA Cancer J Clin 46:113–125CrossRef
30.
Zurück zum Zitat Chen X, Liu X, Wu Q (2013) Biological effects of liposome-mediated MAPK ASO on human laryngeal cancer cell Hep-2. Int J Lab Med 34:2073–2077 Chen X, Liu X, Wu Q (2013) Biological effects of liposome-mediated MAPK ASO on human laryngeal cancer cell Hep-2. Int J Lab Med 34:2073–2077
31.
Zurück zum Zitat Xu CZ, Shi RJ, Chen D, Sun YY, Wu QW, Wang T, Wang PH (2013) Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell. Int J Clin Exp Pathol 6:2745–2756PubMedPubMedCentral Xu CZ, Shi RJ, Chen D, Sun YY, Wu QW, Wang T, Wang PH (2013) Potential biomarkers for paclitaxel sensitivity in hypopharynx cancer cell. Int J Clin Exp Pathol 6:2745–2756PubMedPubMedCentral
32.
Zurück zum Zitat Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357CrossRef Gumbiner BM (1996) Cell adhesion: the molecular basis of tissue architecture and morphogenesis. Cell 84:345–357CrossRef
33.
Zurück zum Zitat Cavallaro U, Christofori G (2016) Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta 1552:39–45 Cavallaro U, Christofori G (2016) Cell adhesion in tumor invasion and metastasis: loss of the glue is not enough. Biochim Biophys Acta 1552:39–45
34.
Zurück zum Zitat Hirohashi S (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153:333–339CrossRef Hirohashi S (1998) Inactivation of the E-cadherin-mediated cell adhesion system in human cancers. Am J Pathol 153:333–339CrossRef
35.
Zurück zum Zitat Yamada D, Yoshida M, Williams YN, Fukami T, Kikuchi S, Masuda M, Maruyama T, Ohta T, Nakae D, Maekawa A (2006) Disruption of spermatogenic cell adhesion and male infertility in mice lacking TSLC1/IGSF4, an immunoglobulin superfamily cell adhesion molecule. Mol Cell Biol 26:3610–3624CrossRef Yamada D, Yoshida M, Williams YN, Fukami T, Kikuchi S, Masuda M, Maruyama T, Ohta T, Nakae D, Maekawa A (2006) Disruption of spermatogenic cell adhesion and male infertility in mice lacking TSLC1/IGSF4, an immunoglobulin superfamily cell adhesion molecule. Mol Cell Biol 26:3610–3624CrossRef
36.
Zurück zum Zitat Shingai T, Ikeda W, Kakunaga S, Morimoto K, Takekuni K, Itoh S, Satoh K, Takeuchi M, Imai T, Monden M (2003) Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells. J Biol Chem 278:773–787CrossRef Shingai T, Ikeda W, Kakunaga S, Morimoto K, Takekuni K, Itoh S, Satoh K, Takeuchi M, Imai T, Monden M (2003) Implications of nectin-like molecule-2/IGSF4/RA175/SgIGSF/TSLC1/SynCAM1 in cell-cell adhesion and transmembrane protein localization in epithelial cells. J Biol Chem 278:773–787CrossRef
37.
Zurück zum Zitat Mao X, Seidlitz E, Truant R, Hitt M, Ghosh HP (2004) Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth. Oncogene 23:5632–5642CrossRef Mao X, Seidlitz E, Truant R, Hitt M, Ghosh HP (2004) Re-expression of TSLC1 in a non-small-cell lung cancer cell line induces apoptosis and inhibits tumor growth. Oncogene 23:5632–5642CrossRef
38.
Zurück zum Zitat Chen K, Wang G, Peng L, Liu S, Fu X, Zhou Y, Yu H, Li A, Li J, Zhang S (2015) CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease. Int J Cancer 128:266–273CrossRef Chen K, Wang G, Peng L, Liu S, Fu X, Zhou Y, Yu H, Li A, Li J, Zhang S (2015) CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease. Int J Cancer 128:266–273CrossRef
39.
Zurück zum Zitat Lu B, Wang H, Ma H, Li J, Zhang Q (2012) Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway. Tumor Biology 33:2007–2017CrossRef Lu B, Wang H, Ma H, Li J, Zhang Q (2012) Tumor suppressor TSLC1 is implicated in cell proliferation, invasion and apoptosis in laryngeal squamous cell carcinoma by regulating Akt signaling pathway. Tumor Biology 33:2007–2017CrossRef
40.
Zurück zum Zitat Mcavoy S, Ganapathiraju SC, Ducharmesmith AL, Pritchett JR, Kosari F, Perez DS, Zhu Y, James CD, Smith DI (2007) Non-random inactivation of large common fragile site genes in different cancers. Cytogenet Genome Res 118:260–269CrossRef Mcavoy S, Ganapathiraju SC, Ducharmesmith AL, Pritchett JR, Kosari F, Perez DS, Zhu Y, James CD, Smith DI (2007) Non-random inactivation of large common fragile site genes in different cancers. Cytogenet Genome Res 118:260–269CrossRef
41.
Zurück zum Zitat Yang M, Park JY, Tae K (2011) Genome-wide evidence of XPC alteration in laryngeal squamous cell carcinomas. Asian Pac J Cancer Prev APJCP 12:1477–1481PubMed Yang M, Park JY, Tae K (2011) Genome-wide evidence of XPC alteration in laryngeal squamous cell carcinomas. Asian Pac J Cancer Prev APJCP 12:1477–1481PubMed
42.
Zurück zum Zitat Yuan Y, Nymoen DA, Dong HP et al (2009) Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions. Hum Pathol 40:1453–1460CrossRef Yuan Y, Nymoen DA, Dong HP et al (2009) Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions. Hum Pathol 40:1453–1460CrossRef
43.
Zurück zum Zitat Chen YQ, Guillemin GJ (2009) Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res 2:1–19CrossRef Chen YQ, Guillemin GJ (2009) Kynurenine pathway metabolites in humans: disease and healthy states. Int J Tryptophan Res 2:1–19CrossRef
Metadaten
Titel
The identification of induction chemo-sensitivity genes of laryngeal squamous cell carcinoma and their clinical utilization
verfasst von
Lianhe Li
Ru Wang
Shizhi He
Xixi Shen
Fanyong Kong
Shuchun Li
Huanhu Zhao
Meng Lian
Jugao Fang
Publikationsdatum
28.09.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 11/2018
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-018-5134-x

Neu im Fachgebiet HNO

Ab sofort gelten die neuen Verordnungsausnahmen für Lipidsenker

Freie Fahrt für Lipidsenker? Das nicht, doch mit niedrigerem Schwellenwert fürs Infarktrisiko und neuen Indikationen hat der G-BA die Verordnungs-Handbremse ein gutes Stück weit gelockert.

Riesenzellarteriitis: bilaterale Biopsie der Temporalarterien von Vorteil

Falls zur diagnostischen Sicherung einer Riesenzellarteriitis (RZA) eine Biopsie der Temporalarterien (TAB) erforderlich ist, scheint die bilaterale TAB der unilateralen überlegen zu sein.

 Diese Version des Artikels wurde inhaltlich überarbeitet und erneut veröffentlicht.

Lagerungsschwindel hält trotz Manöver an: Was steckt dahinter?

Ob sich ein benigner paroxysmaler Lagerungsschwindel erfolgreich behandeln lässt, könnte einem chinesischen Team zufolge auch von psychischen Faktoren abhängen.

Zi veröffentlicht Ranking zur Fehleranfälligkeit gängiger Praxis-EDV

Welches Praxisverwaltungssystem macht am wenigsten Probleme? Das Zi dokumentiert jetzt detaillierte Produktbewertungen zu 17 konkreten Anwendungssituationen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.